Skip to main content

Table 1 Baseline characteristics of patients with COVID-19

From: Subcutaneous injection of IFN alpha-2b for COVID-19: an observational study

  LPV/r group (n = 22) Combination group (n = 19) P-value
Age, year (mean ± SD) 62.0 ± 9.4 56.2 ± 9.7 0.058
Male, n (%) 8 (36) 10 (53) 0.295
Days from symptom onset to hospital admission (mean ± SD) 11 ± 6.8 12 ± 7.3 0.214
Coexisting medical conditions, n (%)
 Hypertension 5 (22.7) 4 (21.1) 1.000
 Diabetes 5 (22.7) 6 (31.6) 0.524
 Hepatitis 1 (4.5) 0 (0) 1.000
 Malignancy 1 (4.5) 2 (10.5) 0.895
Symptoms, n (%)
 Cough 13 (59) 10 (52.6) 0.678
 Shortness of breath 6 (27.3) 4 (21.1) 0.922
 Pharyngalgia 2 (9) 4 (21.1) 0.524
 Arthralgia/myalgia 7 (31.8) 4 (21.1) 0.438
 Chest pain 4 (18.2) 2 (10.5) 0.804
 Fatigue 7 (31.8) 9 (47.4) 0.309